Abstract:Background: A lack of understanding of the processes involved in the absorption and transfer of the ubiquinol form of Coenzyme Q10 has led to a situation in which incorrect marketing claims are being made for the absorption of ubiquinol supplements, possibly misleading physicians and patients in the selection of a Coenzyme Q10 supplement for heart health benefits.In clinical trials, the ubiquinone form of Coenzyme Q10 has been associated with significantly improved symptoms and survival in patients with heart failure and significantly improved heart function and reduced cardiovascular mortality in community-living senior citizens. The ubiquinone form is the more stable and more extensively researched form. The ubiquinol form is unstable by virtue of being an electron donor that is easily oxidized to the ubiquinone form. Nevertheless, insufficiently documented marketing claims are being made for ubiquinol supplements. Methods: To investigate whether or not oral ubiquinol from supplements is absorbed in the ubiquinol form or ubiquinone form, our labs conducted 2 studies of the instability of ubiquinol supplements: a lab study of 13 ubiquinol products sold in the United States and an in vivo study of ubiquinol absorption in large dogs. Results: In the lab study, 76% to 84% of the oral ubiquinol in the nutritional supplements was oxidized to ubiquinone at body temperature in an 8.2 pH solution simulating small intestinal juice. That is to say, much of the oral ubiquinol had been converted to ubiquinone in the sort of pH environment that it would encounter prior to absorption. In a similar fashion, the percentage of ubiquinol converted to ubiquinone increased as the capsule contents passed through the stomach and small intestines of the study dogs. Conclusions: Based on the data from the lab study and the large dog study, we concluded that ubiquinol in commercial nutritional supplements will most likely be oxidized to ubiquinone before it reaches the absorption cells and that the Coenzyme Q10 in the ubiquinol supplements will be absorbed predominantly in the ubiquinone state, transfer into the lymph nodes predominantly in the ubiquinone state and be reduced back to ubiquinol in the lymphatic system.

Bioavailability of Coenzyme Q10: An Overview of the Absorption Process and Subsequent Metabolism

Bioavailability enhancement of coenzyme Q10: An update of novel approaches

The Instability of the Lipid-Soluble Antioxidant Ubiquinol: Part 3-Misleading Marketing Claims

Relative bioavailability comparison of different coenzyme Q10 formulations with a novel delivery system

CoQ10 a super-vitamin: review on application and biosynthesis

A New Food-grade Coenzyme Q10 Formulation Improves Bioavailability: Single and Repeated Pharmacokinetic Studies in Healthy Volunteers

Comparison of the relative bioavailability of different coenzyme Q10 formulations with a novel solubilizate (Solu Q10)

Comparative Bioavailability of Different Coenzyme Q10 Formulations in Healthy Elderly Individuals

Understanding Coenzyme Q

The Cocrystal of Ubiquinol: Improved Stability and Bioavailability

CoQ10 Bioaccessibility and Caco-2 Cell Uptake Improved with Novel Medium Chain Triglyceride Encapsulation

Emulsification using highly hydrophilic surfactants improves the absorption of orally administered coenzyme Q10

Orally ingested ubiquinol-10 or ubiquinone-10 reaches the intestinal tract and is absorbed by the small intestine of mice mostly in its original form

Bioavailability of coenzyme Q10 loaded in an oleogel formulation for oral therapy: Comparison with a commercial-grade solid formulation

Disorders of Human Coenzyme Q10 Metabolism: An Overview

Primary Coenzyme Q10 Deficiency: An Update

Comparison of Coenzyme Q10 (Ubiquinone) and Reduced Coenzyme Q10 (Ubiquinol) as Supplement to Prevent Cardiovascular Disease and Reduce Cardiovascular Mortality

Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations

Biosynthesis, Deficiency, and Supplementation of Coenzyme Q

Characterization and pharmacokinetics of coenzyme Q 10 nanoparticles prepared by a rapid expansion of supercritical solution process